Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p16-mediated G0/G1 cell cycle arrest leads to SASP and fibrosis in Fuchs endothelial corneal dystrophy. | Cell Death Dis | 2026 | 41629264 | PubTator, text mining | PubMed |
| HIV impairs and exploits pulmonary Th17 and Th22 cell-mediated immune responses to Mycobacterium tuberculosis. | PLoS Pathog | 2026 | 41616237 | PubTator, text mining | PubMed |
| Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis. | PLoS One | 2026 | 41575986 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Effects of combined prenatal exposure to air pollution and maternal stress on immune and dopaminergic gene expression in the gut-brain axis. | Brain Behav Immun Health | 2026 | 41561480 | PubTator, text mining | PubMed |
| Antibodies to watch in 2026. | MAbs | 2026 | 41560619 | PubTator, text mining | PubMed |
| Ulcerative pyoderma gangrenosum in a 78-year-old woman treated with brodalumab: A case report. | SAGE Open Med Case Rep | 2026 | 41551110 | PubTator, text mining | PubMed |
| Network pharmacology-based elucidation of the regulatory mechanism of Solanum lyratum (Bai Ying) against psoriasis via the IL-17A/STAT3 axis: Molecular docking and HaCaT cell validation. | Pak J Pharm Sci | 2026 | 41546581 | PubTator, text mining | PubMed |
| Overexpression of the IL-23/IL-17A Axis and Their Receptors (IL-23R and IL-17RA) in Gingival Tissue of Patients With Periodontitis. | Int J Dent | 2026 | 41536464 | PubTator, text mining | PubMed |
| Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors. | Int J Mol Sci | 2026 | 41516330 | PubTator, text mining | PubMed |
| The interplay between the extracellular matrix and extracellular vesicle-associated microRNAs. | Cell Commun Signal | 2026 | 41495757 | PubTator, text mining | PubMed |
| IL17-related gene polymorphisms associated with orbital inflammatory diseases and their clinical features. | Exp Eye Res | 2026 | 41490611 | PubTator, text mining | PubMed |
| Interleukin-17 receptor A drives cancer stem-like properties in colorectal cancer through STAT3 activation. | J Cancer | 2026 | 41438576 | PubTator, text mining | PubMed |
| ALKBH5 promotes gastric cancer angiogenesis by stabilizing LncRNA PVT1 and VEGFA RNAs via m6A demethylation. | Mol Cell Biochem | 2026 | 41428170 | PubTator, text mining | PubMed |
| The central role of IL-17 in cancer stemness and immune evasion: A novel axis for overcoming immune checkpoint inhibitor resistance. | Crit Rev Oncol Hematol | 2026 | 41176077 | PubTator, text mining | PubMed |
| Deciphering the inhibitory mechanisms of Interleukin-17A through dynamic molecular insights: a path toward novel anti-inflammatory therapies. | Mol Divers | 2026 | 40591233 | PubTator, text mining | PubMed |
| Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab. | Dermatol Reports | 2026 | 40457932 | PubTator, text mining | PubMed |
| Expression of IL-17RA in innate cells of patients with common variable immunodeficiency (CVID) and its clinical implications. | Eur Ann Allergy Clin Immunol | 2026 | 38259136 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa. | Front Immunol | 2025 | 41766817 | PubTator, text mining | PubMed |
| Phlorotannins from Ecklonia cava Regulate Dual Signaling Pathways, IL-17RA/Act1 and ERK1/2, to Suppress Ovarian Cancer Progression and Tumor-Associated Macrophage Activation. | Mar Drugs | 2025 | 41590709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=5